Revasum, Inc. reported earnings results for the full year ended January 02, 2022. For the full year, the company reported sales was USD 13.71 million compared to USD 15.37 million a year ago. Net loss was USD 1.97 million compared to USD 9.16 million a year ago.

Basic loss per share from continuing operations was USD 0.02 compared to USD 0.12 a year ago.